| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Savara Inc | Director | Common Stock | 22.5K | $100K | $4.45 | Dec 14, 2023 | Direct |
| Savara Inc | Director | Stock Option (Right to Buy) | 40K | Dec 13, 2022 | Direct | ||
| Arcutis Biotherapeutics, Inc. | Director | Stock Option (Right to Buy) | 13.4K | Jun 9, 2021 | Direct | ||
| Annexon, Inc. | Director | Stock Option (Right to Buy) | 10K | Jun 2, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SVRA | Savara Inc | Dec 14, 2023 | 1 | $0 | 4 | Dec 15, 2023 | Director |
| SVRA | Savara Inc | Dec 13, 2022 | 1 | $0 | 4 | Dec 15, 2022 | Director |
| SVRA | Savara Inc | Dec 14, 2021 | 1 | $0 | 4 | Dec 15, 2021 | Director |
| ARQT | Arcutis Biotherapeutics, Inc. | Jun 9, 2021 | 1 | $0 | 4 | Jun 11, 2021 | Director |
| ANNX | Annexon, Inc. | Jun 2, 2021 | 1 | $0 | 4 | Jun 4, 2021 | Director |